The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy

被引:36
作者
Beresford, M
Glynne-Jones, R
Richman, P
Makris, A
Mawdsley, S
Stott, D
Harrison, M
Osborne, M
Ashford, R
Grainger, J
Al-Jabbour, J
Talbot, I
Mitchell, IC
Thomas, JM
Livingstone, JI
McCue, J
MacDonald, P
Northover, JAM
Windsor, A
Novell, R
Wallace, M
Harrison, RA
机构
[1] Mt Vernon Canc Ctr, Northwood, Middx, England
[2] Univ Hertfordshire, HRDSU, Hatfield AL10 9AB, Herts, England
[3] Barnet Hosp, Barnet, Herts, England
[4] Watford Dist Gen Hosp, Watford, Herts, England
[5] St Marks Hosp, Harrow, Middx, England
[6] Queen Elizabeth II Hosp, Welwyn Garden City, Herts, England
[7] Luton & Dunstable Hosp, Luton, Herts, England
关键词
chemoradiation; lymph nodes; rectal adenocarcinoma;
D O I
10.1016/j.clon.2005.05.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: To determine the prognostic significance of the nodal stage and number of nodes recovered in the surgical specimen after preoperative synchronous chemoradiation (SCRT) and surgery for locally advanced or unresectable rectal cancer. Materials and Methods: One hundred and eighty-two consecutive patients with locally advanced or unresectable (T3/T4) rectal carcinomas were entered on a prospective database and treated in this department with preoperative chemoradiation, followed 6-12 weeks later by surgical resection. Most patients received chemotherapy in the form of low-dose folinic acid and 5-fluorouracil (5-FU) 350 mg/m(2) via a 60-min infusion on days 1-5 and 29-33 of a course of pelvic radiotherapy delivered at a dose of 45 Gy in 25 fractions over 33 days to a planned volume. After resection, patients with a positive circumferential margin (<= 1 mm), extranodal deposits or Dukes' C histology received adjuvant 5-FU-based-chemotherapy (n = 40). Results: After SCRT, 161 patients underwent resection. Twenty-one patients remained unresectable or refused an exenterative operation. Median follow-up is 36 months. Down-staging was achieved in most patients, with 19 having a complete pathological response (pT0). The median number of lymph nodes recovered for all patients was five (range 0-21). The 3-year survival rate for node-positive patients is 47%, for node-negative patients with less than three lymph nodes recovered is 62% and for node-negative patients with three or more lymph nodes recovered is 70%. Compared with node-positive patients, simple regression models revealed a reduced hazard ratio (HR) of 0.72 (0.36-1.43) for node-negative patients with less than three nodes recovered and 0.48 (0.26-0.89) for node-negative patients with three or more lymph nodes recovered. In a multivariate model, including nodal status, excision status, age and sex only positive excision margins significantly predicted a poor outcome: HR = 3.05 (1.55-5.97). Conclusions: The number of nodes found after preoperative chemoradiation is a significant prognostic factor by univariate analysis. In this study, patients with node-negative histology, and at least three nodes recovered, had better long-term survival than patients in whom two or less nodes were recovered or with positive nodes. This effect was attenuated by the inclusion of excision status in multivariate models.
引用
收藏
页码:448 / 455
页数:8
相关论文
共 34 条
[1]   Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma [J].
Bedrosian, I ;
Rodriguez-Bigas, MA ;
Feig, B ;
Hunt, KK ;
Ellis, L ;
Curley, SA ;
Vauthey, JN ;
Delclos, M ;
Crane, C ;
Janjan, N ;
Skibber, JM .
JOURNAL OF GASTROINTESTINAL SURGERY, 2004, 8 (01) :56-62
[2]   Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging [J].
Brown, G ;
Radcliffe, AG ;
Newcombe, RG ;
Dallimore, NS ;
Bourne, MW ;
Williams, GT .
BRITISH JOURNAL OF SURGERY, 2003, 90 (03) :355-364
[3]   Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence [J].
Burdy, G ;
Panis, Y ;
Alves, A ;
Nemeth, J ;
Lavergne-Slove, A ;
Valleur, P .
DISEASES OF THE COLON & RECTUM, 2001, 44 (11) :1682-1688
[4]   Preoperative radiotherapy for resectable rectal cancer -: A meta-analysis [J].
Cammà, C ;
Giunta, M ;
Fiorica, F ;
Pagliaro, L ;
Craxì, A ;
Cottone, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (08) :1008-1015
[5]  
Caplin S, 1998, CANCER, V83, P666, DOI 10.1002/(SICI)1097-0142(19980815)83:4<666::AID-CNCR6>3.3.CO
[6]  
2-S
[7]   Pathological features of rectal cancer after preoperative radiochemotherapy [J].
Dworak, O ;
Keilholz, L ;
Hoffmann, A .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1997, 12 (01) :19-23
[8]   POSTOPERATIVE ADJUVANT CHEMOTHERAPY OR RADIATION-THERAPY FOR RECTAL-CANCER - RESULTS FROM NSABP PROTOCOL R-01 [J].
FISHER, B ;
WOLMARK, N ;
ROCKETTE, H ;
REDMOND, C ;
DEUTSCH, M ;
WICKERHAM, DL ;
FISHER, ER ;
CAPLAN, R ;
JONES, J ;
LERNER, H ;
GORDON, P ;
FELDMAN, M ;
CRUZ, A ;
LEGAULTPOISSON, S ;
WEXLER, M ;
LAWRENCE, W ;
ROBIDOUX, A .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (01) :21-29
[9]   Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial [J].
Francois, Y ;
Nemoz, CJ ;
Baulieux, J ;
Vignal, J ;
Grandjean, JP ;
Partensky, C ;
Souquet, JC ;
Adeleine, P ;
Gerard, JP .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2396-2402
[10]  
Goldstein NS, 1996, AM J CLIN PATHOL, V106, P209